tiprankstipranks
Advertisement
Advertisement

SEPN Stock Latest News

Septerna Shareholders Elect Directors, Ratify Ernst & Young
Company AnnouncementsSepterna Shareholders Elect Directors, Ratify Ernst & Young
11h ago
8K
SEPN
Septerna initiated with a Buy at Guggenheim
PremiumThe Fly
Septerna initiated with a Buy at Guggenheim
20d ago
SEPN
Septerna to present preclinical characterization of SEP-479
PremiumThe Fly
Septerna to present preclinical characterization of SEP-479
23d ago
SEPN
Septerna price target raised to $53 from $47 at Raymond James
PremiumThe Fly
Septerna price target raised to $53 from $47 at Raymond James
23d ago
SEPN
3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026
PremiumMarket News
3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026
1M ago
ANGO
KRNT
Septerna Initiated with Buy Rating on Advancing GPCR Pipeline, Strong Early Data and Novo Nordisk Partnership Support
PremiumRatingsSepterna Initiated with Buy Rating on Advancing GPCR Pipeline, Strong Early Data and Novo Nordisk Partnership Support
2M ago
SEPN
Septerna reports Q1 EPS (19c), consensus (27c)
Premium
The Fly
Septerna reports Q1 EPS (19c), consensus (27c)
2M ago
SEPN
Septerna initiated with a Buy at Stifel
Premium
The Fly
Septerna initiated with a Buy at Stifel
2M ago
SEPN
3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
PremiumMarket News
3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
3M ago
ALLT
CLBT
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
PremiumRatings
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
3M ago
SEPN
Septerna Begins Phase 1 Trial of Oral SEP-479
PremiumCompany Announcements
Septerna Begins Phase 1 Trial of Oral SEP-479
3M ago
8K
SEPN
Septerna doses first patients in SEP-479 trial
PremiumThe Fly
Septerna doses first patients in SEP-479 trial
3M ago
SEPN
Septerna price target raised to $38 from $34 at JPMorgan
PremiumThe FlySepterna price target raised to $38 from $34 at JPMorgan
3M ago
SEPN
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
3M ago
SEPN
Septerna price target raised to $35 from $34 at Truist
Premium
The Fly
Septerna price target raised to $35 from $34 at Truist
4M ago
SEPN
Septerna files automatic mixed securities shelf
PremiumThe Fly
Septerna files automatic mixed securities shelf
4M ago
SEPN
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
PremiumRatings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
4M ago
SEPN
Septerna reports Q4 EPS (24c), consensus (22c)
PremiumThe Fly
Septerna reports Q4 EPS (24c), consensus (22c)
4M ago
SEPN
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
PremiumRatings
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
4M ago
SEPN
Septerna price target raised to $40 from $35 at H.C. Wainwright
PremiumThe FlySepterna price target raised to $40 from $35 at H.C. Wainwright
4M ago
SEPN
Septerna Advances SEP-631 After Positive Phase 1 Results
Premium
Company Announcements
Septerna Advances SEP-631 After Positive Phase 1 Results
4M ago
8K
SEPN
Septerna announces results from Phase 1 trial of SEP-631
Premium
The Fly
Septerna announces results from Phase 1 trial of SEP-631
4M ago
SEPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >